FMS (FMS) Stock Price & Analysis
FMS (FMS) rose 2.57% to USD 22.35 as of June 10, 2026 at 00:59 UTC, according to Nexqual real-time market data.
FMS last closed at USD 21.79; the session ranged USD 22.16–22.5 on volume of 559,738 shares. Market capitalization is $12.00B, with a 52-week range of USD 20.02–29.07 (NYQ). Source: Nexqual, June 10, 2026 at 00:59 UTC.
Key Statistics (as of June 10, 2026 at 00:59 UTC)
| Price | USD 22.35 |
|---|---|
| Change | ▲ 2.57% (up) |
| Previous Close | USD 21.79 |
| Open | USD 22.17 |
| Day Range | USD 22.16 – 22.5 |
| 52-Week Range | USD 20.02 – 29.07 |
| Volume | 559,738 shares |
| Market Cap | $12.00B |
| Exchange | NYQ |
Technical Analysis (FMS)
Nexqual's technical model rates FMS "BUY" based on 4 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 00:59 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.92 (neutral) |
| vs SMA50 | Above (USD 22.24) |
| MACD | -0.11 (negative) |
Analyst Ratings (FMS)
Wall Street analysts rate FMS "Hold" based on 7 analysts, with a mean price target of USD 26.51 (range USD 17.85–37.75), per Nexqual as of June 10, 2026 at 00:59 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 26.51 |
| High Target | USD 37.75 |
| Low Target | USD 17.85 |
| Buy / Hold / Sell | 2 / 3 / 2 |
Earnings (FMS)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.49 |
| Revenue Estimate | $4.73B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.46 vs est 0.5 ▼ miss |
| 2025-12-31 | USD 0.72 vs est 0.55 ▲ beat |
| 2025-09-30 | USD 0.55 vs est 0.5 ▲ beat |
| 2025-06-30 | USD 0.46 vs est 0.47 ▼ miss |
Source: Nexqual, June 10, 2026 at 00:59 UTC.
Financials & Fundamentals (FMS)
| Total Revenue | $19.36B |
|---|---|
| Revenue Growth (YoY) | -5.50% |
| Gross Margin | +25.96% |
| Operating Margin | +8.14% |
| Profit Margin | +4.88% |
| ROE | +7.85% |
| Debt / Equity | 77.75 |
| Current Ratio | 1.21 |
| Total Cash | $1.24B |
| Total Debt | $11.04B |
| Free Cash Flow | $1.67B |
Source: Nexqual, June 10, 2026 at 00:59 UTC.
Financial Health Score (FMS)
Nexqual rates FMS's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:59 UTC.
| Growth | Mixed — Revenue +1.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 26%, operating 8% |
| Balance Sheet | Mixed — $1.24B cash vs $11.0B debt |
| Cash Flow | Solid — FCF $1.67B, 9% margin |
| Efficiency | Mixed — ROE 8%, ROA 3.6% |
Ownership (FMS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +9.75% |
| Shares Outstanding | 537.13M |
| Float | 369.38M |
Source: Nexqual, June 10, 2026 at 00:59 UTC.
Leadership (FMS)
FMS is led by Helen Giza (age 57), Chair of Management Board & CEO, per Nexqual as of June 10, 2026 at 00:59 UTC.
| Chair of Management Board & CEO | Helen Giza (age 57) |
|---|---|
| CFO & Member of the Management Board | Martin Fischer (age 47) |
| Member of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director | Jorg Haring (age 55) |
| Senior Vice President of Corporate Communications & Governmental Affairs | Joachim Weith |
| Senior Vice President of Research & Development | Gail-Suzanne Brown |
Major Backers & Investors (FMS)
Notable institutional backers of FMS include Pzena Investment Management LLC, Dodge & Cox Inc., Fiduciary Management, Inc., according to Nexqual as of June 10, 2026 at 00:59 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Pzena Investment Management LLC | 2.79% |
| Dodge & Cox Inc. | 1.42% |
| Fiduciary Management, Inc. | 0.83% |
| Morgan Stanley | 0.46% |
| Millennium Management | 0.3% |
| Brandes Investment Partners L.P. | 0.3% |
| Todd Asset Management LLC | 0.24% |
| FMI Funds Inc-Large Cap Fund | 0.22% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.99% |
Source: Nexqual, June 10, 2026 at 00:59 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNN | Smith & Nephew SNATS, Inc. | USD 31.32 | ▲ 2.32% |
| DVA | DaVita Inc. | USD 198.19 | ▲ 3.14% |
| UHS | Universal Health Services, Inc. | USD 146.59 | ▲ 0.98% |
| GRFS | Grifols, S.A. | USD 7.34 | ▼ 3.93% |
| MD | Pediatrix Medical Group, Inc. | USD 23.66 | ▲ 4.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:59 UTC. This page is informational and not investment advice.